INTRODUCTION AND OBJECTIVES: Extended PACU length of stay (PLOS) can frustrate patients and physicians, delay postoperative care pathways, and potentially increase cost. Predictors of increased PLOS are unknown. We examined patient-specific factors and cost in relation to PLOS.
METHODS: The NSQIP (National Surgery Quality Improvement Program) database was queried for our institution to identify patients treated with open radical cystectomy (RC), robotic prostatectomy (RP), laparoscopic nephrectomy (LN), and minimally invasive partial nephrectomy (MIS PN) by CPT code. Perioperative data, PLOS, and finance data were analyzed.
RESULTS: 787 cases were included. Median PLOS (MPLOS) was 5.0 hours (IQR 3.0-8.0, Table 1 ). Overnight PLOS (OPLOS) occurred in 132 pts (17.7%). Among preoperative variables, PLOS was longer in patients with preoperative dyspnea (p<0.01), creatinine >1.3, (p<0.01) or BUN >21, (p<0.05). Higher ASA class was associated with longer MPLOS, (p<0.01). MPLOS for patients undergoing RP and RC was slightly shorter than for renal cases (4 hrs vs 5 hrs, p<0.05). Increased PLOS was not associated with postoperative complications. OPLOS was more expensive with a median total cost $16,800 vs $15,900 (p<0.05), and had higher median total hospital charges, $58,300 vs $51,800 (p[0.004). OPLOS carried more direct ($11,200 vs $10,500; p[0.049) and indirect costs, ($5,400 vs $5,100; p[0.016). Operating room and floor direct costs were higher in the OPLOS cohort compared to the non-OPLOS cohort, $9,000 vs $7,800 (p[0.015), and $1,200 vs $1,000 (p[0.02), respectively. There was no association between PLOS and overall hospital LOS (p[0.400).
CONCLUSIONS: ASA class, preoperative dyspnea, renal dysfunction, and surgery type were associated with increased PLOS. OPLOS significantly increases cost but is not associated with increased complication rate. Non-patient specific characteristics such as bed occupancy may come into play and should be further investigated to improve quality of care. Contemporary data highlights an increase in PNB related infections particularly when performed via the transrectal approach. Noninfectious complications, however, may similarly contribute to biopsy related morbidity. Appropriate patient counseling merits recognition and discussion of such risks. Therefore, we review the incidence and predictors of non-infectious complications following PNB in a large quality registry.
METHODS: The Pennsylvania Urologic Regional Collaboration (PURC) is a physician-led quality collaborative focusing on prostate cancer diagnosis and therapy. Established in 2015, 9 participating practices encompassing 108 urologists have accrued over 8,100 men into this data registry. The incidence and distribution of non-infectious PNB complications were evaluated. Logistic regression determined the association of clinical and pathologic variables with the most common non-infectious complications.
RESULTS: 8,102 men underwent a transrectal ultrasound guided biopsy of which 84% were an initial biopsy, 11% had one prior biopsy, and 5% had multiple prior biopsies. 277 of 8,102 (3.4%) men experienced a biopsy related complication including 199 (2.5%) that were non-infectious and 78 (0.9%) that were infection-related (p<0.001). The most common non-infectious complications included bleeding (n[74; 0.9%) and urinary retention (n[70; 0.9%). Of the 199 non-infectious complications, 111 (56%) resulted in an ED visit and 54 (27%) were admitted to the hospital. With respect to postbiopsy urinary retention, increasing gland size (OR 1.07 per 5cc increase, 95% CI 1. 01À1.11, p[0.002) CONCLUSIONS: Non-infectious complications following biopsy occurred in 2.5% of men with bleeding (0.9%) and urinary retention (0.9%) being the most common causes. Over 50% of these noninfectious complications required an ED visit and over one-quarter needed hospital admission. Such information provides an important framework in counseling patients regarding expectations following prostate biopsy. 
